MissionIR Articles
-
MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds
NextPlat (NASDAQ: NXPL, NXPLW) reported Q1 2025 revenue of $14.5 million, down from $17.5 million in the prior year, driven by changes in 340B pharmacy agreements and prescription volume. Gross margin declined to 23.8%, while operating expenses fell 26% to $4.9 million due to reduced legal and non-recurring costs. Net loss narrowed to $1.3 million, or…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing FDA discussions. The company launched an Early Access Program, signed a strategic partnership with AccurKardia to integrate its FDA-cleared AccurECG(TM) software, added two new U.S. patents to…
-
MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Converts Super Voting Shares to Support Nasdaq Uplisting Plans
FAVO Capital (OTC: FAVO), a private credit firm focused on merchant cash advances and revenue-based financing for underserved SMBs, announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock. The move simplifies the company’s capital structure, eliminates super voting rights, and aligns with public market governance standards as FAVO continues…
-
MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins
Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications
CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete…
-
MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute
NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to acquire the Kadima Neuropsychiatry Institute. Kadima, a leading California clinic for interventional psychiatry, offers treatments such as ketamine, Spravato, transcranial magnetic stimulation (TMS), and medication management for CNS disorders including suicidal depression and PTSD. The clinic is…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Record Revenue, Gross Profit and Cash Balance along with Quantum Supremacy Breakthrough in Q1
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted record first quarter 2025 revenue of $15 million, up 509% from the prior year. Business and financial results for the quarter included the first Advantage™ annealing quantum computer sale and publication of breakthrough research demonstrating quantum supremacy on a real-world problem.…
-
MissionIRNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Files C$200 Million Shelf Prospectus for Flexible Future Offerings
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) has filed a final short form base shelf prospectus with Canadian securities regulators, replacing its previous version set to expire in June 2025. The new Shelf Prospectus allows the company to offer up to C$200 million in securities—including common shares, debt instruments, warrants, and…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Showcases Fast Motion Shaft Innovation on TechMediaWire Podcast
Newton Golf Company (NASDAQ: NWTG) Co-Founder and CTO Aki Yorihiro appeared on the latest episode of IBN’s TechMediaWire Podcast to discuss the company’s Fast Motion Shaft, now in use on the PGA TOUR Champions, LPGA, and Korn Ferry Tours. Yorihiro outlined how the shaft’s speed-optimized design and Newton’s proprietary fitting system are reshaping performance standards…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Bollinger Delivers EV Truck to LES Ecology Center
Mullen Automotive (NASDAQ: MULN) announced that its subsidiary, Bollinger Motors, has delivered a Bollinger B4 all-electric Class 4 commercial vehicle to the Lower East Side Ecology Center in New York City. Funded by the NYC Council, the truck will support composting and environmental programs as the LES Ecology Center’s first EV. The B4, equipped with…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) CEO to Present Live via Skyline Signature Series on May 7
FingerMotion (NASDAQ: FNGR), a mobile services, data and technology company, announced that CEO Martin J. Shen will deliver a live corporate presentation on Wednesday, May 7, at 12 p.m. ET as part of the Skyline Signature Series. The virtual event, hosted by Skyline Corporate Communications Group, will include a live Q&A session following the presentation,…
-
MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) to Announce Q1 2025 Results on May 15, Hosts Investor Call at 8:30 a.m.
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, will release its financial results for the quarter ended March 31, 2025, before market open on May 15. Management will host a conference call at 8:30 a.m. EDT the same day, led by Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and President and CEO…
-
MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Ramps Up Innovation, Logistics to Power Growth
Massimo (NASDAQ: MAMO) is making strategic moves to actively enhance its position in the powersports and recreational vehicle industry. The company is expanding its retail partnership with Rural King to include a wider range of products, while optimizing logistics with a new distribution center in Illinois and mitigating tariff risks and enhancing quality with Texas-based golf…
-
MissionIRNewsBreaks – Freight Technologies (Nasdaq: FRGT) Secures $20 Million Facility to Acquire Trump Tokens as Part of Digital Asset Strategy
Freight Technologies, Inc. (Nasdaq: FRGT) has entered into a convertible note agreement for up to $20 million with an institutional investor, earmarking proceeds to purchase Official Trump Tokens ($TRUMP) as a core part of its crypto treasury. The initial $1 million tranche supports Fr8Tech’s broader digital asset diversification following its recent $8 million investment in…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13
HeartBeam (NASDAQ: BEAT) will host a conference call on May 13 at 4:30 p.m. Eastern to discuss financial results for the first quarter ended March 31, 2025. CEO Robert Eno and CFO Timothy Cruickshank will lead the call, which will include updates on regulatory progress, commercial-readiness efforts, and upcoming milestones. A corresponding press release and presentation…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Launches Next Phase of Drilling at Iska Iska Silver-Tin Project
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), advancing its Iska Iska silver-tin polymetallic project in southwestern Bolivia, will soon begin a 4,300-meter, eight-hole diamond drilling program targeting the Santa Barbara starter pit area. The campaign is designed to upgrade and expand high-grade tin and silver mineralization, with holes spaced at 50 meters to confirm…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early-stage cutaneous T-cell lymphoma (“CTCL”). Building on the success of a prior phase 3 trial, HyBryte(TM)—which uses synthetic hypericin activated by safe visible light—offers a potentially game-changing approach by providing a…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Partners With Demora Foundation To Power K-Entertainment Tokenization Platform
- MissionIRNewsBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Explores Multi-Vein Potential at Idaho Clayton Project
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Reports 2025 Results, Expands Margins Amid Strategic Shift